These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2886716)

  • 1. Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients.
    Tayek JA; Heber D; Chlebowski RT
    Lancet; 1987 Aug; 2(8553):241-4. PubMed ID: 2886716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Chlebowski RT; Heber D; Richardson B; Block JB
    Cancer Res; 1984 Feb; 44(2):857-61. PubMed ID: 6692384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.
    Chlebowski RT; Bulcavage L; Grosvenor M; Oktay E; Block JB; Chlebowski JS; Ali I; Elashoff R
    J Clin Oncol; 1990 Jan; 8(1):9-15. PubMed ID: 1688616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.
    Kosty MP; Fleishman SB; Herndon JE; Coughlin K; Kornblith AB; Scalzo A; Morris JC; Mortimer J; Green MR
    J Clin Oncol; 1994 Jun; 12(6):1113-20. PubMed ID: 8201372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience.
    Chlebowski RT; Bulcavage L; Grosvenor M; Tsunokai R; Block JB; Heber D; Scrooc M; Chlebowski JS; Chi J; Oktay E
    Cancer; 1987 Feb; 59(3):406-10. PubMed ID: 3791153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrazine sulfate: a current perspective.
    Gold J
    Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled randomized study of hydrazine sulfate in lung cancer.
    Kosty MP; Herndon JE; Green MR; McIntyre OR
    J Clin Oncol; 1995 Jun; 13(6):1529-30. PubMed ID: 7751903
    [No Abstract]   [Full Text] [Related]  

  • 8. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
    Loprinzi CL; Goldberg RM; Su JQ; Mailliard JA; Kuross SA; Maksymiuk AW; Kugler JW; Jett JR; Ghosh C; Pfeifle DM
    J Clin Oncol; 1994 Jun; 12(6):1126-9. PubMed ID: 8201374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
    Loprinzi CL; Kuross SA; O'Fallon JR; Gesme DH; Gerstner JB; Rospond RM; Cobau CD; Goldberg RM
    J Clin Oncol; 1994 Jun; 12(6):1121-5. PubMed ID: 8201373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer.
    Melville S; McNurlan MA; Calder AG; Garlick PJ
    Cancer Res; 1990 Feb; 50(4):1125-31. PubMed ID: 2297761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine and protein metabolism in young women. Subdivision based on the novel use of multiple stable isotopic labels.
    Irving CS; Thomas MR; Malphus EW; Marks L; Wong WW; Boutton TW; Klein PD
    J Clin Invest; 1986 Apr; 77(4):1321-31. PubMed ID: 3082937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body protein breakdown rates and hormonal adaptation in fasted obese subjects.
    Henson LC; Heber D
    J Clin Endocrinol Metab; 1983 Aug; 57(2):316-9. PubMed ID: 6408111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.
    Frey N; Jang JH; Szer J; Illés Á; Kim HJ; Ram R; Chong BH; Rowe JM; Borisenkova E; Liesveld J; Winer ES; Cherfi A; Aslanis V; Ghaznawi F; Strickland S
    Lancet Haematol; 2019 Mar; 6(3):e122-e131. PubMed ID: 30704923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of hydrazine sulfate in advanced cancer patients.
    Spremulli E; Wampler GL; Regelson W
    Cancer Chemother Pharmacol; 1979; 3(2):121-4. PubMed ID: 389477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
    Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
    Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.